Yoshitaka Matsubayashi

Yoshitaka Matsubayashi

Auto-generated profile, based on publicly available information

Yoshitaka Matsubayashi

Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Japan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YMYoshitaka Matsubayashi
Yoshitaka Matsubayashi
KTKatsushi Takeshita
Katsushi Takeshita
MSMasahiko Sumitani
Masahiko Sumitani
YOYasushi Oshima
Yasushi Oshima
JTJuichi Tonosu
Juichi Tonosu
STSakae Tanaka
Sakae Tanaka
The aim of this study was to evaluate the validity and reliability of the Japanese version of the painDETECT questionnaire (PDQ-J). The translation of the original PDQ into Japanese was achieved according to the published guidelines. Subsequently, a multicenter observational study was performed to evaluate the validity and reliability of PDQ-J, including 113 Japanese patients suffering from pain. Factor analysis revealed that the main component of PDQ-J comprises two determinative factors, which account for 62% of the variance observed. Moreover, PDQ-J revealed statistically significant correlation with the intensity of pain (Numerical Rating Scale), Physical Component Score, and Mental Component Score of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36). The Cronbach alpha for the total score was 0.78 and for the main component was 0.80. In the analysis of test–retest method, the intraclass correlation coefficient between the two scores was 0.94. We demonstrated the validity and reliability of PDQ-J. We encourage researchers and clinicians to use this tool for the assessment of patients who suffer suspected neuropathic pain.

15 May 2019 in Spine
Verified
Journal Article
Closed access
SKSo Kato
So Kato
YOYasushi Oshima
Yasushi Oshima
YMYoshitaka Matsubayashi
Yoshitaka Matsubayashi
YTYuki Taniguchi
Yuki Taniguchi
STSakae Tanaka
Sakae Tanaka
KTKatsushi Takeshita
Katsushi Takeshita
Study Design.: A retrospective analysis. Objective.: The aim of this study was to elucidate the psychometric properties of the original Japanese Orthopaedic Association (JOA) score, including the minimum detectable change (MDC), minimum clinically important difference (MCID), and patient-accepted symptom state (PASS). Summary of Background Data.: Despite the worldwide popularity of modified JOA score (mJOA), the original JOA score is still commonly used in East Asian countries, including Japan. However, unlike mJOA score, the psychometric properties of JOA score remain poorly understood. Methods.: We retrospectively reviewed a consecutive series of laminoplasty for degenerative cervical myelopathy patients in a single academic institution. Pre- and postoperative JOA scores were collected, and the recovery rate was calculated. Anchor-based methods were used to determine the cut-off values by a receiver operating characteristic (ROC) curve analysis. The patients were also asked to answer an anchor question analyzing their postoperative health transition used for the MDC and another question assessing the patient satisfaction used for the MCID and PASS. Results.: A total of 101 patients were included in the analysis. The mean preoperative JOA score was 10.3 [standard deviation (SD): 2.4), and the mean postoperative JOA score was 13.4 (SD: 2.5). The mean recovery rate was 44%. A total of 68% of the patients admitted that their health condition was at least “somewhat better” than their preoperative condition, and 66% were at least “somewhat satisfied” with the treatment results. On the basis of ROC curve analyses, the MDC and MCID for JOA score in degenerative cervical myelopathy patients were calculated to be 2.5. The PASS was estimated to be 14.5, and the MCID for JOA recovery rate was 52.8%. Conclusion.: The MDC, MCID, and PASS for JOA score for degenerative cervical myelopathy patients were reported by anchor-based ROC curve analyses. Level of Evidence: 4

1 January 2016 in Pain Research and Management
Verified
Journal Article
Open access
PDF file
JHJun Hozumi
Jun Hozumi
MSMasahiko Sumitani
Masahiko Sumitani
YMYoshitaka Matsubayashi
Yoshitaka Matsubayashi
HAHiroaki Abe
Hiroaki Abe
YOYasushi Oshima
Yasushi Oshima
YYYoshitsugu Yamada
Yoshitsugu Yamada
Objectives. Overweight negatively affects musculoskeletal health; hence obesity is considered a risk factor for osteoarthritis and chronic low back pain. This was conducted to determine if obesity affects neuropathic pain, usually considered unrelated to the weight-load on the musculoskeletal system.Methods. Using a cut-off body mass index value of 25, 44 patients with neuropathic pain were grouped into a “high-BMI” group and a “normal-BMI” group.Results. The numeric rating scale of the high-BMI group was significantly higher than that of the normal-weight group (P<0.05). The total NPSI scores were significantly higher (P<0.01), and the paroxysmal pain and the negative symptoms were more serious in the high-BMI group than in the normal-BMI group. The high-BMI subjects also had significantly higher SF-MPQ scores (P<0.05). However, both physical and mental health status on the SF-36 were comparable between the groups.Discussion. Neuropathic pain that did not arise from musculoskeletal damage was higher in the high-BMI patients. Paroxysmal pain was more severe, suggesting that neural damage might be aggravated by obesity-associated inflammation. These findings should have needed to be confirmed in future studies.

14 March 2019 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
SKSo Kato
So Kato
YOYasushi Oshima
Yasushi Oshima
YMYoshitaka Matsubayashi
Yoshitaka Matsubayashi
YTYuki Taniguchi
Yuki Taniguchi
STSakae Tanaka
Sakae Tanaka
KTKatsushi Takeshita
Katsushi Takeshita

19 August 2022 in Science Advances
Verified
Journal Article
Open access
NTNaohiro Tachibana
Naohiro Tachibana
RCRyota Chijimatsu
Ryota Chijimatsu
HOHiroyuki Okada
Hiroyuki Okada
TOTakeshi Oichi
Takeshi Oichi
YTYuki Taniguchi
Yuki Taniguchi
TSTaku Saito
Taku Saito
Ectopic endochondral ossification in the tendon/ligament is caused by repetitive mechanical overload or inflammation. Tendon stem/progenitor cells (TSPCs) contribute to tissue repair, and some express lubricin [proteoglycan 4 (PRG4)]. However, the mechanisms of ectopic ossification and association of TSPCs are not yet known. Here, we investigated the characteristics of Prg4-positive ( + ) cells and identified that R-spondin 2 (RSPO2), a WNT activator, is specifically expressed in a distinct Prg4 + TSPC cluster. The Rspo2 + cluster was characterized as mostly undifferentiated, and RSPO2 overexpression suppressed ectopic ossification in a mouse Achilles tendon puncture model via chondrogenic differentiation suppression. RSPO2 expression levels in patients with ossification of the posterior longitudinal ligament were lower than those in spondylosis patients, and RSPO2 protein suppressed chondrogenic differentiation of human ligament cells. RSPO2 was induced by inflammatory stimulation and mechanical loading via nuclear factor κB. Rspo2 + cells may contribute to tendon/ligament homeostasis under pathogenic conditions.

5 November 2020 in Global Spine Journal
Verified
Journal Article
Open access
PDF file
YOYasushi Oshima
Yasushi Oshima
KTKatsushi Takeshita
Katsushi Takeshita
SKSo Kato
So Kato
TDToru Doi
Toru Doi
YMYoshitaka Matsubayashi
Yoshitaka Matsubayashi
STSakae Tanaka
Sakae Tanaka
Study Design: A retrospective cohort study. Objective: To investigate whether the Japanese Orthopaedic Association (JOA) score can be used for patients with degenerative cervical myelopathy as a patient-reported outcome (PRO) through the JOA written questionnaire. Methods: A total of 75 patients who underwent posterior decompression surgery for degenerative cervical myelopathy were reviewed. Patients responded to questionnaires including PRO-JOA, EuroQOL-5D, Neck Disability Index, and Short Form-12 preoperatively and at >12 months postoperatively. Spearman’s rho and Bland-Altman analyses were used to investigate the correlations. Results: Preoperative JOA and PRO-JOA scores were 10.8 and 10.6, respectively, with Spearman’s rho of 0.74. Similarly, postoperative JOA and PRO-JOA scores were 13.3 and 12.9, respectively, with Spearman’s rho of 0.68. However, the recovery rates for JOA and PRO-JOA scores were 42% and 27%, respectively, with Spearman’s rho of 0.45. Compared with other PROs, JOA and PRO-JOA scores were moderately correlated. The minimum clinically important difference was 2.5 for JOA score, 3.0 for PRO-JOA score, 42% for JOA recovery rate, and 33% for PRO-JOA recovery rate. Bland-Altman analyses revealed that limits of agreement were −4.3 to 4.7, −3.4 to 4.3, and −75% to 106% for the preoperative score, postoperative score, and recovery rate, respectively. Conclusion: PRO-JOA score can also be used as a disease-specific scoring measure instead of JOA score. However, although both measures demonstrate a similar trend as a group analysis, PRO-JOA and JOA scores should be regarded as different outcomes.